Fennec Pharmaceuticals Inc. (TSX:FRX)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2020
Sodium Thiosulfate	21.64M
Sodium Thiosulfate Growth	1368.05%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2020
United States	21.64M
United States Growth	1368.05%